Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Pennsylvania Medicaid, known as Medical Assistance (MA) and administered through the Department of Human Services, has limited coverage for GLP-1 medications for obesity without a diabetes diagnosis
In the U.S., MOUNJARO (tirzepatide) is indicated as an adjunct to diet and exercise for glycemic control in adults and pediatric patients aged 10 years and older with insufficiently controlled type 2 diabetes mellitus as monotherapy when metformin is not appropriate, or in addition to other antidiabetic agents.[4] MOUNJARO does not carry a U.S
Provides a stable formulation for research protocols requiring precise compound combinations
Related Reading Semaglutide Vs Tirzepatide 2 Tirzepatide Vs Semaglutide 2 Semaglutide Providers That Take Fsa Plexusdx Tirzepatide Vs Semaglutide Side Effects Pricing and availability current as of June 2026
US$ 27.00
US$ 20.77
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 22.04
US$ 27.50
US$ 20.26
US$ 28.00
US$ 22.16
